Improved Access to CGM Data Empowers Providers and Patients to More Effectively Partner on  Diabetes Management

Continuous Glucose Monitoring tools are revolutionizing the way diabetes is managed, offering unparalleled benefits for both healthcare providers and patients. By providing continuous, accurate data, CGM is especially useful for remote monitoring, enabling timely interventions and leading to better user health. The post Improved Access to CGM Data Empowers Providers and Patients to More Effectively…

Read More

Trump to end the IRA ‘pill penalty’

As reported by EndPoints: President Donald Trump on Tuesday signed an executive order offering support for a change to the IRA’s “pill penalty,” one of the industry’s long-standing policy priorities that could affect billions of dollars in drug costs under Medicare. The executive order on drug pricing contains a grab-bag of policy proposals, some of…

Read More

KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version – The Monitor

This volume shares findings from the KFF/The Washington Post Survey of Parents about exposure to and trust in children’s health content on social media, along with misleading claims following the approval of a generic version of mifepristone, reports of autism possibly being added to the Vaccine Injury Compensation Program, and patients using AI chatbots to…

Read More